Advertisement
Singapore markets closed
  • Straits Times Index

    3,176.51
    -11.15 (-0.35%)
     
  • Nikkei

    37,068.35
    -1,011.35 (-2.66%)
     
  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     
  • FTSE 100

    7,886.93
    +9.88 (+0.13%)
     
  • Bitcoin USD

    64,477.36
    +630.90 (+0.99%)
     
  • CMC Crypto 200

    1,376.01
    +63.38 (+5.08%)
     
  • S&P 500

    4,998.37
    -12.75 (-0.25%)
     
  • Dow

    37,928.79
    +153.41 (+0.41%)
     
  • Nasdaq

    15,466.82
    -134.67 (-0.86%)
     
  • Gold

    2,404.60
    +6.60 (+0.28%)
     
  • Crude Oil

    83.19
    +0.46 (+0.56%)
     
  • 10-Yr Bond

    4.6170
    -0.0300 (-0.65%)
     
  • FTSE Bursa Malaysia

    1,547.57
    +2.81 (+0.18%)
     
  • Jakarta Composite Index

    7,087.32
    -79.50 (-1.11%)
     
  • PSE Index

    6,443.00
    -80.19 (-1.23%)
     

Is Teva Pharmaceuticals Stock a Buy?

Is Teva Pharmaceuticals Stock a Buy?

Teva Pharmaceutical Industries (NYSE: TEVA) is a well known generic drugmaker that's attracted the attention of a number of well-known investors in the past. Most notably, Warren Buffett's Berkshire Hathaway bought shares of the company a number of years ago due, in no small part due to how cheap the stock was at the time. Teva's business can be split up into two main areas: its generics business and its own branded drug products.